AUBN vs SSBI

AUBN exhibits a Piotroski F-Score of 4/9, indicating stable but not robust financial health, while the absence of an Altman Z-Score limits distress risk assessment. The stock trades below its Graham Number of $34.65 at $26.25, suggesting potential undervaluation, though growth expectations are modest with a P/E of 12.62 and strong recent earnings growth. Profitability metrics like a 22.11% profit margin and 32.92% operating margin are solid, but low ROA of 0.71% and missing leverage data raise concerns. Dividend strength is high with a 4.17% yield and sustainable 52.68% payout ratio, but technical trend is bearish and insider sentiment is neutral.

SSBI presents a contradictory profile characterized by a weak Piotroski F-Score of 3/9, indicating poor financial health, and a missing Altman Z-Score. While the stock trades below its Graham Number ($18.43) and Book Value (P/B 0.92), it is significantly overpriced relative to its growth-based Intrinsic Value of $7.07. Massive YoY revenue growth (327.5%) suggests a non-organic event or accounting shift, while a bearish technical trend (10/100) and low ROA (0.66%) signal underlying instability. The valuation is attractive from a defensive standpoint, but the fundamental health is concerning.